Antibody to lymphadenopathy-associated virus in haemophiliacs with and without AIDS
Ramsey, R.B.; Palmer, E.L.; McDougal, J.S.; Kalyanaraman, V.S.; Jackson, D.W.; Chorba, T.L.; Holman, R.C.; Evatt, B.L.
Lancet 2(8399): 397-398
1984
ISSN/ISBN: 0140-6736 PMID: 6147470 DOI: 10.1016/s0140-6736(84)90559-2Document Number: 420851
Document emailed within 0-6 h
Related Documents
Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus Microbiology and Immunology 29(11): 1083-1087Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus Microbiology and Immunology 29(11): 1083-1087
Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus Microbiology and Immunology 29(11): 1083-1087
Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus Microbiology and Immunology 29(11): 1083-1087
Laurence, J.; Brun-Vezinet, F.; Schutzer, S.E.; Rouzioux, C.; Klatzmann, D.; Barré-Sinoussi, F.; Chermann, J.C.; Montagnier, L. 1984: Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state New England Journal of Medicine 311(20): 1269-1273
Rouzioux, C.; Chamaret, S.; Montagnier, L.; Carnelli, V.; Rolland, G.; Mannucci, P.M. 1985: Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated Factor VIIi concentrate Lancet 1(8423): 271-272
Jason, J.; McDougal, J.S.; Holman, R.C.; Stein, S.F.; Lawrence, D.N.; Nicholson, J.K.; Dixon, G.; Doxey, M.; Evatt, B.L. 1985: Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage JAMA 253(23): 3409-3415
Cheingsong-Popov, R.; Weiss, R.A.; Dalgleish, A.; Tedder, R.S.; Shanson, D.C.; Jeffries, D.J.; Ferns, R.B.; Briggs, E.M.; Weller, I.V.; Mitton, S. 1984: Prevalence of antibody to human T-lymphotropic virus type IIi in AIDS and AIDS-risk patients in Britain Lancet 2(8401): 477-480
Madhok, R.; Melbye, M.; Lowe, G.D.; Forbes, C.D.; Froebel, K.S.; Bodner, A.J.; Biggar, R.J. 1985: HTLV-III antibody in sequential plasma samples: from haemophiliacs 1974-84 Lancet 1(8427): 524-525
1986: AIDS in haemophiliacs and homosexuals Lancet 1(8471): 36
1986: AIDS in haemophiliacs and homosexuals Lancet 1(8471): 36
&na, &na; ,, 1987: Immunization of Children Infected with Human T-Lymphotropic Virus type Iii/Lymphadenopathy-Associated Virus The Pediatric Infectious Disease Journal 6(2): 209-211
1985: Leads from the MMWR. Heterosexual transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus JAMA 254(15): 2051-2052
1985: Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace Mmwr. Morbidity and Mortality Weekly Report 34(45): 681
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Kaplan, J.E.; Oleske, J.M.; Getchell, J.P.; Kalyanaraman, V.S.; Minnefor, A.B.; Zabala-Ablan, M.; Joshi, V.; Denny, T.; Cabradilla, C.D.; Rogers, M.F. 1985: Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome Pediatric Infectious Disease 4(5): 468-471
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Kaplan, J.E.; Oleske, J.M.; Getchell, J.P.; Kalyanaraman, V.S.; Minnefor, A.B.; Zabala-Ablan, M.; Joshi, V.; Denny, T.; Cabradilla, C.D.; Rogers, M.F. 1985: Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome Pediatric Infectious Disease 4(5): 468-471
Traisupa, A.; Wongba, C.; Taylor, D.N. 1987: AIDS and prevalence of antibody to human immunodeficiency virus (HIV) in high risk groups in Thailand Genitourinary Medicine 63(2): 106-108
Zarling, J.M.; Eichberg, J.W.; Moran, P.A.; McClure, J.; Sridhar, P.; Hu, S.L. 1987: Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins Journal of Immunology 139(4): 988-990